Therapeutic effect of turquoise versus blue light with equal irradiance in preterm infants with jaundice

Area of Science:

• Neonatal care
• Phototherapy research
• Bilirubin metabolism

Background:

• Neonatal jaundice is a common condition in preterm infants.
• Hyperbilirubinemia requires effective treatment to prevent complications.
• Current phototherapy uses blue light, but its efficiency varies.

Purpose of the Study:

• To compare the efficacy of turquoise light versus standard blue light (TL52) for treating jaundice in preterm infants.
• To evaluate treatment effectiveness at equivalent body irradiance levels.
• To determine the optimal light spectrum for neonatal phototherapy.

Main Methods:

• A comparative study involving preterm infants (28-37 weeks gestation) with non-hemolytic hyperbilirubinemia.
• Infants received 24-hour treatment with either turquoise or blue light at equal irradiance.
• Serum total bilirubin and bilirubin isomer concentrations were measured using routine methods and High-Performance Liquid Chromatography (HPLC).

Main Results:

• Turquoise light demonstrated a significantly greater reduction in total bilirubin and toxic Z,Z-bilirubin levels compared to blue light.
• Treatment with turquoise light resulted in a smaller increase in Z,E-bilirubin.
• A trend towards a higher increase in E,Z-bilirubin was observed with turquoise light therapy.

Conclusions:

• Turquoise light therapy is more efficient than TL52 blue light in reducing bilirubin levels in jaundiced preterm infants at equal irradiances.
• The turquoise spectral range offers superior efficacy due to deeper skin penetration and favorable isomer production.
• Turquoise light is suggested as a preferable alternative to blue light for treating neonatal jaundice.